🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Cliff Asness’s FDMT Holdings & Trades

First Buy
Q1 2025
Duration Held
5 Quarters
Largest Add
Q1 2025
+14,340 Shares
Current Position
45,777 Shares
$426,183 Value

Cliff Asness's FDMT Position Overview

Cliff Asness (via Aqr Capital Management LLC) currently holds 45,777 shares of 4D Molecular Therapeutics, Inc. (FDMT) worth $426,183, representing 0.00% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 5 quarters.

Based on 13F filings, Cliff Asness has maintained this position in FDMT for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 11,721 shares.

Analysis based on 13F filings available since 2013 Q2

Cliff Asness's 4D Molecular Therapeutics (FDMT) Holding Value Over Time

Track share changes against reported price movement

Quarterly 4D Molecular Therapeutics (FDMT) Trades by Cliff Asness

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2026 +9,693 Add 26.86% 45,777 $9.31
Q4 2025 +180 Add 0.50% 36,084 $7.50
Q3 2025 +9,843 Add 37.77% 35,904 $8.69
Q2 2025 +11,721 Add 81.74% 26,061 $3.71
Q1 2025 +14,340 New Buy 14,340 $3.23

Cliff Asness's 4D Molecular Therapeutics Investment FAQs

Cliff Asness first purchased 4D Molecular Therapeutics, Inc. (FDMT) in Q1 2025, acquiring 14,340 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Cliff Asness has held 4D Molecular Therapeutics, Inc. (FDMT) for 5 quarters since Q1 2025.

Cliff Asness's largest addition to 4D Molecular Therapeutics, Inc. (FDMT) was in Q1 2025, adding 14,340 shares worth $46,319.

According to the latest 13F filing for Q1 2026, Cliff Asness's firm, Aqr Capital Management LLC, owns 45,777 shares of 4D Molecular Therapeutics, Inc. (FDMT), valued at approximately $426,183.

As of the Q1 2026 filing, 4D Molecular Therapeutics, Inc. (FDMT) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.

Cliff Asness's peak holding in 4D Molecular Therapeutics, Inc. (FDMT) was 45,777 shares, as reported at the end of Q1 2026.